Lara Bußmann
Dr. med.
Lara Bußmann
  • Medical specialist
  • Research fellow
  • Medical Specialist in Otorhinolaryngology
Working area

Location

Main Building O10 , Ground Floor
Languages
German (Mother tongue)
English

Areas of expertise

Publications

Zurück
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Vor

SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model
Ehm P, Rietow R, Wegner W, Bußmann L, Kriegs M, Dierck K, Horn S, Streichert T, Horstmann M, Jücker M
CELLS-BASEL. 2023;12(13):1798.

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
Oetting A, Christiansen S, Gatzemeier F, Köcher S, Bußmann L, Böttcher A, Stölzel K, Hoffmann A, Struve N, Kriegs M, Petersen C, Betz C, Rothkamm K, Zech H, Rieckmann T
CLIN TRANSL RAD ONCO. 2023;41:100630.

Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib
Vu A, Akingunsade L, Hoffer K, Petersen C, Betz C, Rothkamm K, Rieckmann T, Bussmann L, Kriegs M
HEAD NECK-J SCI SPEC. 2023;45(1):147-155.

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

ANAESTHESIA. 2022;77(1):28-39.

Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinomaA subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN
Jonas H, Simnica D, Bußmann L, Zech H, Doescher J, Laban S, Busch C, Binder M
ORAL ONCOL. 2022;126:.

Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
Schönlein M, Wrage V, Ghandili S, Mellinghoff S, Brehm T, Leypoldt L, Utz N, Schrader R, Alsdorf W, Börschel N, Bußmann L, Schönrock M, Perlick D, Schön G, Verpoort K, Lütgehetmann M, Schulze Zur Wiesch J, Weisel K, Bokemeyer C, Schafhausen P, Sinn M
CANCER CELL. 2022;40(6):581-583.

Increased replication stress and R-loop accumulation in EGFRvIII expressing glioblastoma present new therapeutic opportunities
Struve N, Hoffer K, Weik A, Riepen B, Krug L, Cetin M, Burmester J, Ott L, Liebing J, Gatzemeier F, Müller-Goebel J, Bußmann L, Parplys A, Unger K, Mansour W, Schüller U, Rieckmann T, Petersen C, Rothkamm K, Short S, Kriegs M
NEURO-ONCOL ADV. 2022;4(1):vdab180.

Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer
Zech H, Berger J, Mansour W, Nordquist L, von Bargen C, Bußmann L, Oetting A, Christiansen S, Möckelmann N, Böttcher A, Busch C, Petersen C, Betz C, Rothkamm K, Kriegs M, Köcher S, Rieckmann T
RADIOTHER ONCOL. 2022;168:138-146.

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

BRIT J SURG. 2021;108(9):1056-1063.

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.

ANAESTHESIA. 2021;76(6):748-758.

Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors
Berger J, Zech H, Hoffer K, von Bargen C, Nordquist L, Bussmann L, Gatzemeier F, Busch C, Möckelmann N, Münscher A, Betz C, Petersen C, Rothkamm K, Rieckmann T, Köcher S, Kriegs M
ORAL ONCOL. 2021;123:.

Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas
Böttcher A, Betz C, Bartels S, Schönnagel B, Münscher A, Bußmann L, Busch C, Knopke S, Bibiza-Freiwald E, Möckelmann N
J CANCER RES CLIN. 2021;147(2):549-559.

Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets
Bußmann L, Hoffer K, von Bargen C, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu A, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann L, Zech H, Berger J, Möckelmann N, Busch C, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz T, Betz C, Petersen C, Rothkamm K, Münscher A, Kriegs M
INT J CANCER. 2021;149(5):1166 - 1180.

83/m mit Schwellung am Hals: Vorbereitung auf die Facharztprüfung: Fall 24
Zech H, Schafhausen P, Bußmann L
ONKOLOGE. 2021.

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC)
Bußmann L, Laban S, Wittekindt C, Stromberger C, Tribius S, Möckelmann N, Böttcher A, Betz C, Klussmann J, Budach V, Muenscher A, Busch C
BMC CANCER. 2020;20(1):701.

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
Struve N, Binder Z, Stead L, Brend T, Bagley S, Faulkner C, Ott L, Müller-Goebel J, Weik A, Hoffer K, Krug L, Rieckmann T, Bußmann L, Henze M, Morrissette J, Kurian K, Schüller U, Petersen C, Rothkamm K, O Rourke D, Short S, Kriegs M
ONCOGENE. 2020;39(15):3041-3055.

Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC
Beizaei K, Gleißner L, Hoffer K, Bußmann L, Vu A, Steinmeister L, Laban S, Möckelmann N, Münscher A, Petersen C, Rothkamm K, Kriegs M
HEAD NECK-J SCI SPEC. 2019;41(1):208-215.

Tumor volume as a predictive parameter in the sequential therapy (induction chemotherapy) of head and neck squamous cell carcinomas
Bohlen M, Busch C, Sehner S, Forterre F, Bier J, Berliner C, Bußmann L, Münscher A
EUR ARCH OTO-RHINO-L. 2019;276(4):1183-1189.

Analyzing expression and phosphorylation of the EGF receptor in HNSCC
Kriegs M, Clauditz T, Hoffer K, Bartels J, Buhs S, Gerull H, Zech H, Bußmann L, Struve N, Rieckmann T, Petersen C, Betz C, Rothkamm K, Nollau P, Münscher A
SCI REP-UK. 2019;9(1):13564.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2019
Zech H, Laban S, Schafhausen P, Bussmann L, Betz C, Busch C
HNO. 2019;67(12):898-904.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2018
Bußmann L, Münscher A, Busch C
HNO. 2018;66(12):907-912.

Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor
Schmidt D, Rodat T, Heintze L, Weber J, Horbert R, Girreser U, Raeker T, Bußmann L, Kriegs M, Hartke B, Peifer C
CHEMMEDCHEM. 2018;13(22):2415-2426.

Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients
Busch C, Girke J, Tribius S, Bussmann L, Knecht R, Schafhausen P, Lörincz B, Münscher A
CLIN OTOLARYNGOL. 2017;42(6):1392-1396.

Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches
Münscher A, Bussmann L, Sehner S, Knaack S, Gliese A, Tribius S, Clauditz T, Lörincz B
EUR ARCH OTO-RHINO-L. 2017;274(8):3211-3219.

Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016
Bußmann L, Busch C, Knecht R
HNO. 2016;64(10):723-30.

Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer
Bussmann L, Busch C, Lörincz B, Rieckmann T, Block A, Knecht R
EUR ARCH OTO-RHINO-L. 2016;273(12):4073-4080.

Ist Radio(chemo)therapie wirklich der zukünftige Standard für die Behandlung von Oropharynxkarzinomen?
Knecht R, Bussmann L, Möckelmann N, Lörincz B
HNO. 2016;64(4):221-6.

Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria
Ayuketang F, Veit R, Zabelina T, Bussmann L, Christopeit M, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N
ANN HEMATOL. 2015;94(10):1727-32.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs:Highlights des ASCO-Meetings 2015
Bußmann L, Busch C, Knecht R
HNO. 2015;63(9):620-4.

Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation
Ayuketang F, Bussmann L, Zabelina T, Veit R, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N
ANN HEMATOL. 2014;93(5):855-61.

Letzte Aktualisierung aus dem FIS: 28.03.2024 - 05:52 Uhr